Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000587476 | SCV000569661 | uncertain significance | not provided | 2018-10-16 | criteria provided, single submitter | clinical testing | This variant is denoted APC c.1405C>T at the DNA level. This variant is silent at the coding level, preserving a Leucine at codon 469. In-silico analysis, which includes splice predictors and evolutionary conservation, supports that this variant does not alter protein structure/function. This variant has not, to our knowledge, been published in the literature as a pathogenic or benign germline variant. This variant was not observed at a significant allele frequency in large population cohorts (Lek 2016). Based on currently available evidence, it is unclear whether APC c.1405C>T is a pathogenic or benign variant. We consider it to be a variant of uncertain significance. |
Labcorp Genetics |
RCV003766682 | SCV000647173 | likely benign | Familial adenomatous polyposis 1 | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000562539 | SCV000667396 | likely benign | Hereditary cancer-predisposing syndrome | 2015-05-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000855609 | SCV000693995 | likely benign | not specified | 2019-08-20 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000562539 | SCV000909244 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-28 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000587476 | SCV004219646 | likely benign | not provided | 2022-12-21 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004003331 | SCV004837395 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003766682 | SCV004932098 | benign | Familial adenomatous polyposis 1 | 2024-03-01 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |